Mackie I C, Hobson P
Department of Oral Health and Development, University Dental Hospital of Manchester, England.
Int J Paediatr Dent. 1993 Sep;3(3):163-7. doi: 10.1111/j.1365-263x.1993.tb00074.x.
Because use of sugar-containing paediatric medicines is an aetiological factor in dental caries, sugar-free alternatives are slowly becoming more readily available. However, it is claimed that, for a variety of reasons, their production is difficult. This investigation was undertaken to determine whether problems exist in the formulation, production and availability of sugar-free medicines. A structured questionnaire was used with personnel involved in the production, marketing and wholesaling of paediatric medicines in the UK. Information was obtained from interviews with, or from questionnaires completed by, personnel of five pharmaceutical and five wholesale companies. The findings indicated that the only obstacle to producing sugar-free medicines is slightly higher cost, and that manufacturers are influenced to change mainly by consumer pressure. It was concluded that the dental profession should advise the public to demand sugar-free medicines and doctors to prescribe them.